Final FDA 510(k) Substantial Equivalence Guidance

FDA issued a final guidance entitled “The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]” dated July 28.2014. This guidance mentions software 18 times (including in the example). Software is considered one of the technological characteristics that could affect equivalence and examples include changes in the way software is used to analyze a patient’s anatomy or physiology.. The guidance also discusses the software information to be provided in the 510(k) related to demonstating substantial equivalence. The full guidance is at the link provided.

FDA and 62304 Training – Boston – June 4-6, 2019

3-day course is designed to gain an understanding of how 62304 and other standards can be implemented efficiently and effectively while meeting FDA expectations as well.  John F. Murray, Jr., will be among the faculty!
The discounted April registration expires on April 30, 2019, or when all discounted seats are sold.

Corporate Office

+1-781-721-2921
Partners located in the US (CA, FL, MA, MN, TN) and Italy.